Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
DU ›
DUSAVI
Trademark search for:
DUSAVI
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-10-11 — Application filed
2017-10-14 — Application filed
2017-10-18 — Application filed
2018-01-10 — Assigned to examiner
2018-01-11 — Final disposition recorded
2018-01-11 — Final disposition recorded
2018-01-11 — Final disposition recorded
2018-05-29 — Office action issued
2018-05-29 — Correspondence received in law office
2018-05-30 — Teas/email correspondence entered
2018-05-31 — Suspension letter written
2018-05-31 — Letter of suspension e-mailed
2018-05-31 — Notification of letter of suspension e-mailed
2018-06-07 — Undeliverable mail - courtesy copy mailed
2019-01-11 — Assigned to lie
2019-01-11 — Report completed suspension check case still suspended
2019-07-11 — Report completed suspension check case still suspended
2020-01-14 — Report completed suspension check case still suspended
2020-07-15 — Report completed suspension check case still suspended
2021-03-08 — Suspension checked - to attorney for action
2021-03-08 — Final disposition recorded
2021-03-08 — Final disposition recorded
2021-03-08 — Final disposition recorded
2021-09-20 — Application abandoned
2021-09-20 — Application abandoned
2021-09-20 — Final status recorded
Owner Information
Teva Pharmaceuticals USA, Inc.
North Wales , PA
Correspondent
HERSCHEL PEREL TEVA PHARMACEUTICALS USA, INC. 425 PRIVET ROAD TRADEMARKS DEPARTMENT HORSHAM, PA 19044
Filing Details
Filing Date:
2017-10-11
Status Date:
2021-09-20
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.